Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial (CANVAS Trial)

NCT02744092 is registered in ClinicalTrials.gov with Alliance Foundation Trials, LLC. as lead sponsor.

NCT NCT02744092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02744092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial (CANVAS Trial)
Lead sponsor
Alliance Foundation Trials, LLC.
Phase
Not applicable
Overall status
Completed
Start date
December 13, 2016
Completion date
February 22, 2021
Enrollment
811 (actual)
Sites
151

Conditions

As the registry lists them; a condition with its own page is linked.

blood clot, cancer, deep vein thrombosis (dvt), pulmonary embolism (pe), venous thromboembolism